Literature DB >> 6873516

Immunoprecipitation of 125I-insulin crosslinked receptor.

T Tsushima, Y Ohmori, H Murakami, K Shizume, Y Hirata.   

Abstract

125I-insulin was covalently crosslinked to its receptor on human placental membrane fractions with disuccinimidyl suberate. The 125I-insulin crosslinked receptor was solubilized with Triton X-100 and used as a probe to determine autoantibodies to the insulin receptor in sera from patients with insulin resistance (type B syndrome). When the solubilized 125I-insulin: receptor complex was incubated with these sera and then with anti-human IgG serum, the complex was precipitated as a function of the amount of anti-receptor serum. Unlabelled insulin at concentrations less than or equal to 10 micrograms/ml did not affect immunoprecipitation of the complex, suggesting that a subpopulation of anti-receptor antibodies recognizes determinants outside the insulin binding region of the receptor molecule. 125I-insulin: receptor complex was precipitated also by the addition of anti-insulin antibodies. The effect of anti-insulin antibody was eliminated by the addition of excess unlabelled insulin. The immunoprecipitation assay using 125I-insulin crosslinked receptor was sensitive and convenient for detecting anti-receptor antibodies.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6873516     DOI: 10.1007/bf00251830

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  15 in total

1.  The effect of solubilization on the properties of the insulin receptor of human placental membranes.

Authors:  L C Harrison; T Billington; I J East; R J Nichols; S Clark
Journal:  Endocrinology       Date:  1978-05       Impact factor: 4.736

2.  Direct demonstration that receptor crosslinking or aggregation is important in insulin action.

Authors:  C R Kahn; K L Baird; D B Jarrett; J S Flier
Journal:  Proc Natl Acad Sci U S A       Date:  1978-09       Impact factor: 11.205

3.  Insulin receptors in human and animal placental tissue.

Authors:  B I Posner
Journal:  Diabetes       Date:  1974-03       Impact factor: 9.461

4.  Purification of the adipocyte insulin receptor by immunoaffinity chromatography.

Authors:  J Heinrich; P F Pilch; M P Czech
Journal:  J Biol Chem       Date:  1980-02-25       Impact factor: 5.157

5.  Interaction of cross-linking agents with the insulin effector system of isolated fat cells. Covalent linkage of 125I-insulin to a plasma membrane receptor protein of 140,000 daltons.

Authors:  P F Pilch; M P Czech
Journal:  J Biol Chem       Date:  1979-05-10       Impact factor: 5.157

6.  Autoantibodies against the insulin receptor recognize the insulin binding subunits of an oligomeric receptor.

Authors:  M Kasuga; E van Obberghen; K M Yamada; L C Harrison
Journal:  Diabetes       Date:  1981-04       Impact factor: 9.461

7.  The subunit structure of the high affinity insulin receptor. Evidence for a disulfide-linked receptor complex in fat cell and liver plasma membranes.

Authors:  P F Pilch; M P Czech
Journal:  J Biol Chem       Date:  1980-02-25       Impact factor: 5.157

8.  Characterization of antibodies to the insulin receptor: a cause of insulin-resistant diabetes in man.

Authors:  J S Flier; C R Kahn; D B Jarrett; J Roth
Journal:  J Clin Invest       Date:  1976-12       Impact factor: 14.808

9.  Direct demonstration of glycosylation of insulin receptor subunits by biosynthetic and external labeling: evidence for heterogeneity.

Authors:  J A Hedo; M Kasuga; E Van Obberghen; J Roth; C R Kahn
Journal:  Proc Natl Acad Sci U S A       Date:  1981-08       Impact factor: 11.205

10.  Biosynthetic labeling of insulin receptor: studies of subunits in cultured human IM-9 lymphocytes.

Authors:  E Van Obberghen; M Ksauga; A Le Cam; J A Hedo; A Itin; L C Harrison
Journal:  Proc Natl Acad Sci U S A       Date:  1981-02       Impact factor: 11.205

View more
  2 in total

1.  Nonbinding inhibitory antiinsulin receptor antibodies. A new type of autoantibodies in human diabetes.

Authors:  G Boden; Y Fujita-Yamaguchi; R Shimoyama; J J Shelmet; L Tappy; I Rezvani; O E Owen
Journal:  J Clin Invest       Date:  1988-06       Impact factor: 14.808

2.  Defective processing of insulin-receptor precursor in cultured lymphocytes from a patient with extreme insulin resistance.

Authors:  T Kakehi; A Hisatomi; H Kuzuya; Y Yoshimasa; M Okamoto; K Yamada; H Nishimura; A Kosaki; H Nawata; F Umeda
Journal:  J Clin Invest       Date:  1988-06       Impact factor: 14.808

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.